SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001126234-22-000101
Filing Date
2022-09-06
Accepted
2022-09-06 16:55:43
Documents
1
Period of Report
2022-09-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_166249772778882.html 4  
1 FORM 4 wf-form4_166249772778882.xml 4 4367
  Complete submission text file 0001126234-22-000101.txt   5814
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 512-215-2630
LUMOS PHARMA, INC. (Issuer) CIK: 0001126234 (see all company filings)

IRS No.: 421491350 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1360 WILLOW ROAD #100 MENLO PARK CA 94025
Business Address
Karpf David B (Reporting) CIK: 0001622067 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35342 | Film No.: 221228878